Schedule 13D ownership disclosure
VOR BIOPHARMA INC
Common Stock, par value $0.0001 per share · CUSIP: 929033108
Event date: 2025-07-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 5AM Ventures VI, L.P.Reported CIK 0001753037
Shares: 3,194,645.00 · Class: 2.6%
- 5AM Partners VI, LLCReported CIK 0001829051
Shares: 3,194,645.00 · Class: 2.6%
- 5AM Opportunities I, L.P.Reported CIK 0001753000
Shares: 1,228,218.00 · Class: 1.0%
- 5AM Opportunities I (GP), LLCReported CIK 0001790778
Shares: 1,228,218.00 · Class: 1.0%
- Andrew J. SchwabReported CIK 0001598549
Shares: 4,422,863.00 · Class: 3.5%
- Kush ParmarReported CIK 0001664281
Shares: 4,422,863.00 · Class: 3.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-019583
- Form type
- SCHEDULE 13D/A
- Filer
- 5AM Ventures VI, L.P.
- CIK
- CIK 1753037
- Filed
- Jul 09, 2025
- Reporting period
- Jul 08, 2025
- Description
- Schedule 13D beneficial ownership